Annual EPS
-$330.00
+$61.50+15.71%
December 31, 2023
Summary
- As of February 26, 2025, TCRT annual earnings per share is -$330.00, with the most recent change of +$61.50 (+15.71%) on December 31, 2023.
- During the last 3 years, TCRT annual EPS has fallen by -$273.00 (-478.95%).
- TCRT annual EPS is now -329.17% below its all-time high of $144.00, reached on December 31, 2018.
Performance
TCRT EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.70
+$0.01+1.41%
September 30, 2024
Summary
- As of February 26, 2025, TCRT quarterly earnings per share is -$0.70, with the most recent change of +$0.01 (+1.41%) on September 30, 2024.
- Over the past year, TCRT quarterly EPS has increased by +$0.01 (+1.41%).
- TCRT quarterly EPS is now -100.36% below its all-time high of $193.50, reached on December 31, 2018.
Performance
TCRT Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$7.41
+$4.60+38.31%
September 30, 2024
Summary
- As of February 26, 2025, TCRT TTM earnings per share is -$7.41, with the most recent change of +$4.60 (+38.31%) on September 30, 2024.
- Over the past year, TCRT TTM EPS has increased by +$4.60 (+38.31%).
- TCRT TTM EPS is now -104.99% below its all-time high of $148.50, reached on June 30, 2019.
Performance
TCRT TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
TCRT EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.7% | +1.4% | +38.3% |
| 3 y3 years | -478.9% | +95.8% | +88.5% |
| 5 y5 years | -329.2% | +95.3% | +86.7% |
TCRT EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -494.6% | +15.7% | at high | +90.7% | at high | +86.7% |
| 5 y | 5-year | -494.6% | +15.7% | at high | +95.8% | at high | +92.9% |
| alltime | all time | -329.2% | +94.5% | -100.4% | +100.0% | -105.0% | +99.9% |
Alaunos Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.70(-1.4%) | -$7.41(-38.3%) |
| Jun 2024 | - | -$0.71(-35.5%) | -$12.01(-28.5%) |
| Mar 2024 | - | -$1.10(-77.5%) | -$16.79(-23.6%) |
| Dec 2023 | -$330.00(-15.7%) | -$4.90(-7.6%) | -$21.99(-4.8%) |
| Sep 2023 | - | -$5.30(-3.5%) | -$23.09(-2.9%) |
| Jun 2023 | - | -$5.49(-12.9%) | -$23.79(-7.8%) |
| Mar 2023 | - | -$6.30(+5.0%) | -$25.80(-4.4%) |
| Dec 2022 | -$391.50(+605.4%) | -$6.00(0.0%) | -$27.00(-5.3%) |
| Sep 2022 | - | -$6.00(-20.0%) | -$28.50(-26.9%) |
| Jun 2022 | - | -$7.50(0.0%) | -$39.00(-18.8%) |
| Mar 2022 | - | -$7.50(0.0%) | -$48.00(-13.5%) |
| Dec 2021 | -$55.50(-2.6%) | -$7.50(-54.5%) | -$55.50(-14.0%) |
| Sep 2021 | - | -$16.50(0.0%) | -$64.50(+2.4%) |
| Jun 2021 | - | -$16.50(+10.0%) | -$63.00(+5.0%) |
| Mar 2021 | - | -$15.00(-9.1%) | -$60.00(+2.6%) |
| Dec 2020 | -$57.00(-45.7%) | -$16.50(+10.0%) | -$58.50(+5.4%) |
| Sep 2020 | - | -$15.00(+11.1%) | -$55.50(-47.1%) |
| Jun 2020 | - | -$13.50(0.0%) | -$105.00(0.0%) |
| Mar 2020 | - | -$13.50(0.0%) | -$105.00(+1.4%) |
| Dec 2019 | -$105.00(-172.9%) | -$13.50(-79.1%) | -$103.50(-200.0%) |
| Sep 2019 | - | -$64.50(+377.8%) | $103.50(-30.3%) |
| Jun 2019 | - | -$13.50(+12.5%) | $148.50(+3.1%) |
| Mar 2019 | - | -$12.00(-106.2%) | $144.00(+7.9%) |
| Dec 2018 | $144.00(-281.1%) | $193.50(-1092.3%) | $133.50(-267.9%) |
| Sep 2018 | - | -$19.50(+8.3%) | -$79.50(0.0%) |
| Jun 2018 | - | -$18.00(-20.0%) | -$79.50(-1.9%) |
| Mar 2018 | - | -$22.50(+15.4%) | -$81.00(0.0%) |
| Dec 2017 | -$79.50(-59.8%) | -$19.50(0.0%) | -$81.00(+3.8%) |
| Sep 2017 | - | -$19.50(0.0%) | -$78.00(+4.0%) |
| Jun 2017 | - | -$19.50(-13.3%) | -$75.00(-63.8%) |
| Mar 2017 | - | -$22.50(+36.4%) | -$207.00(+4.5%) |
| Dec 2016 | -$198.00(+37.5%) | -$16.50(0.0%) | -$198.00(+3.1%) |
| Sep 2016 | - | -$16.50(-89.1%) | -$192.00(-2.3%) |
| Jun 2016 | - | -$151.50(+1022.2%) | -$196.50(+219.5%) |
| Mar 2016 | - | -$13.50(+28.6%) | -$61.50(-59.4%) |
| Dec 2015 | -$144.00(+209.7%) | -$10.50(-50.0%) | -$151.50(-1.9%) |
| Sep 2015 | - | -$21.00(+27.3%) | -$154.50(+8.4%) |
| Jun 2015 | - | -$16.50(-84.1%) | -$142.50(+5.6%) |
| Mar 2015 | - | -$103.50(+666.7%) | -$135.00(+190.3%) |
| Dec 2014 | -$46.50(-53.0%) | -$13.50(+50.0%) | -$46.50(+3.3%) |
| Sep 2014 | - | -$9.00(0.0%) | -$45.00(-31.8%) |
| Jun 2014 | - | -$9.00(-40.0%) | -$66.00(-26.7%) |
| Mar 2014 | - | -$15.00(+25.0%) | -$90.00(-7.7%) |
| Dec 2013 | -$99.00(-45.9%) | -$12.00(-60.0%) | -$97.50(-30.9%) |
| Sep 2013 | - | -$30.00(-9.1%) | -$141.00(-3.1%) |
| Jun 2013 | - | -$33.00(+46.7%) | -$145.50(-7.6%) |
| Mar 2013 | - | -$22.50(-59.5%) | -$157.50(-13.9%) |
| Dec 2012 | -$183.00 | -$55.50(+60.9%) | -$183.00(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$34.50(-23.3%) | -$157.50(+26.5%) |
| Jun 2012 | - | -$45.00(-6.3%) | -$124.50(+20.3%) |
| Mar 2012 | - | -$48.00(+60.0%) | -$103.50(-32.4%) |
| Dec 2011 | -$145.50(+36.6%) | -$30.00(+1900.0%) | -$153.00(-2.9%) |
| Sep 2011 | - | -$1.50(-93.8%) | -$157.50(-19.2%) |
| Jun 2011 | - | -$24.00(-75.4%) | -$195.00(+36.8%) |
| Mar 2011 | - | -$97.50(+182.6%) | -$142.50(+28.4%) |
| Dec 2010 | -$106.50(+115.2%) | -$34.50(-11.5%) | -$111.00(+68.2%) |
| Sep 2010 | - | -$39.00(-236.8%) | -$66.00(+41.9%) |
| Jun 2010 | - | $28.50(-143.2%) | -$46.50(-49.2%) |
| Mar 2010 | - | -$66.00(-728.6%) | -$91.50(+84.8%) |
| Dec 2009 | -$49.50(-72.3%) | $10.50(-153.8%) | -$49.50(-46.8%) |
| Sep 2009 | - | -$19.50(+18.2%) | -$93.00(-17.3%) |
| Jun 2009 | - | -$16.50(-31.3%) | -$112.50(-21.1%) |
| Mar 2009 | - | -$24.00(-27.3%) | -$142.50(-20.8%) |
| Dec 2008 | -$178.50(-15.6%) | -$33.00(-15.4%) | -$180.00(-17.2%) |
| Sep 2008 | - | -$39.00(-16.1%) | -$217.50(-5.8%) |
| Jun 2008 | - | -$46.50(-24.4%) | -$231.00(0.0%) |
| Mar 2008 | - | -$61.50(-12.8%) | -$231.00(+8.5%) |
| Dec 2007 | -$211.50(-0.7%) | -$70.50(+34.3%) | -$213.00(+6.0%) |
| Sep 2007 | - | -$52.50(+12.9%) | -$201.00(+9.8%) |
| Jun 2007 | - | -$46.50(+6.9%) | -$183.00(-9.0%) |
| Mar 2007 | - | -$43.50(-25.6%) | -$201.00(-10.1%) |
| Dec 2006 | -$213.00(-38.8%) | -$58.50(+69.6%) | -$223.50(+3.5%) |
| Sep 2006 | - | -$34.50(-46.5%) | -$215.93(-27.3%) |
| Jun 2006 | - | -$64.50(-2.3%) | -$296.93(-85.6%) |
| Mar 2006 | - | -$66.00(+29.6%) | -$2062.13(-50.8%) |
| Dec 2005 | -$348.00(-94.1%) | -$50.93(-55.9%) | -$4192.97(-39.2%) |
| Sep 2005 | - | -$115.50(-93.7%) | -$6891.52(-15.8%) |
| Jun 2005 | - | -$1829.69(-16.7%) | -$8184.98(+28.4%) |
| Mar 2005 | - | -$2196.85(-20.1%) | -$6372.25(+52.3%) |
| Dec 2004 | -$5942.84(+2809.5%) | -$2749.48(+95.1%) | -$4183.87(+160.4%) |
| Sep 2004 | - | -$1408.96(+8208.9%) | -$1606.65(+670.2%) |
| Jun 2004 | - | -$16.96(+100.2%) | -$208.59(+4.3%) |
| Mar 2004 | - | -$8.47(-95.1%) | -$200.08(-2.0%) |
| Dec 2003 | -$204.26(+284.1%) | -$172.27(+1480.7%) | -$204.26(+340.9%) |
| Sep 2003 | - | -$10.90(+29.1%) | -$46.33(+4.9%) |
| Jun 2003 | - | -$8.44(-33.3%) | -$44.15(-17.6%) |
| Mar 2003 | - | -$12.65(-11.8%) | -$53.56(+0.7%) |
| Dec 2002 | -$53.18(-51.9%) | -$14.34(+64.4%) | -$53.18(-47.1%) |
| Sep 2002 | - | -$8.72(-51.1%) | -$100.46(-2.8%) |
| Jun 2002 | - | -$17.84(+45.3%) | -$103.33(-1.8%) |
| Mar 2002 | - | -$12.28(-80.1%) | -$105.26(-0.7%) |
| Dec 2001 | -$110.57 | -$61.62(+431.9%) | -$105.96(+139.0%) |
| Sep 2001 | - | -$11.59(-41.4%) | -$44.34(-27.4%) |
| Jun 2001 | - | -$19.77(+52.3%) | -$61.06(-12.3%) |
| Mar 2001 | - | -$12.98(-54.1%) | -$69.60(+22.9%) |
| Sep 2000 | - | -$28.31(0.0%) | -$56.61(+100.0%) |
| Jun 2000 | - | -$28.31 | -$28.31 |
FAQ
- What is Alaunos Therapeutics annual earnings per share?
- What is the all time high annual EPS for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual EPS year-on-year change?
- What is Alaunos Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly EPS year-on-year change?
- What is Alaunos Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Alaunos Therapeutics?
- What is Alaunos Therapeutics TTM EPS year-on-year change?
What is Alaunos Therapeutics annual earnings per share?
The current annual EPS of TCRT is -$330.00
What is the all time high annual EPS for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual earnings per share is $144.00
What is Alaunos Therapeutics annual EPS year-on-year change?
Over the past year, TCRT annual earnings per share has changed by +$61.50 (+15.71%)
What is Alaunos Therapeutics quarterly earnings per share?
The current quarterly EPS of TCRT is -$0.70
What is the all time high quarterly EPS for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly earnings per share is $193.50
What is Alaunos Therapeutics quarterly EPS year-on-year change?
Over the past year, TCRT quarterly earnings per share has changed by +$0.01 (+1.41%)
What is Alaunos Therapeutics TTM earnings per share?
The current TTM EPS of TCRT is -$7.41
What is the all time high TTM EPS for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM earnings per share is $148.50
What is Alaunos Therapeutics TTM EPS year-on-year change?
Over the past year, TCRT TTM earnings per share has changed by +$4.60 (+38.31%)